Edwards Lifesciences Corp
NYSE:EW
Edwards Lifesciences Corp
NYSE:EW
Price:
86.25 USD
1.83%
Market Closed
Updated:
May 14, 2024
Edwards Lifesciences Corp
Cost of Revenue
|
Edwards Lifesciences Corp
Cost of Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Cost of Revenue
-$1.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-10%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cost of Revenue
-$11.4B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-11%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cost of Revenue
-$4.5B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-7%
|
|
|
Stryker Corp
NYSE:SYK
|
Cost of Revenue
-$7.5B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cost of Revenue
-$18B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cost of Revenue
-$2.5B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-14%
|
See Also
What is Edwards Lifesciences Corp's Cost of Revenue?
Cost of Revenue
-1.4B
USD
-1.4B
USD
Based on the financial report for Mar 31, 2024, Edwards Lifesciences Corp's Cost of Revenue amounts to -1.4B USD.
What is Edwards Lifesciences Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-10%
-10%
Over the last year, the Cost of Revenue growth was -29%. The average annual Cost of Revenue growth rates for Edwards Lifesciences Corp have been -9% over the past three years , -9% over the past five years , and -10% over the past ten years .
You don't have any saved screeners yet
